Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-24-009243

Dake Benjamin T sold 3,432 shares at $28.01 ($96,119)

  • Dake Benjamin T acquired 3,432 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-25 Exercise or conversion : show line 1 in the form 10b5-1 +3,432 $10.61 $36,414 4,723 D
2024-03-25 Sale : show line 2 in the form 10b5-1 −3,432 $28.01 $96,119 1,291 D
Open-market sales · 3,432 sh · avg $28.01 · $96,119

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-25 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −3,432 40,068 D
Loading xslF345X05/form4-03272024_060301.xml…